Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2016-11-13 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
首次公开发行股票招股意向书
Capital/Financing Update Classification · 95% confidence The document is titled as a 招股意向书, which translates to a "Prospectus" or "Offering Intention Document" related to an initial public offering (IPO). It contains detailed information about the stock issuance, share lock-up commitments by major shareholders and directors, dividend policies, shareholding restrictions, and stock price stabilization plans. It is not a financial report like an annual or interim report, nor is it a regulatory filing or announcement of a report. It is a detailed document related to capital raising and stock issuance for a company going public. Therefore, the document fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes such as IPO prospectuses.
2016-11-13 Chinese
北京国枫律师事务所关于公司申请首次公开发行股票并上市的补充法律意见书之三
Regulatory Filings
2016-11-13 Chinese
非经常性损益专项审核报告（2013年度至2016年6月）
Regulatory Filings
2016-11-13 Chinese
北京国枫律师事务所关于公司申请首次公开发行股票并上市的律师工作报告
Audit Report / Information Classification · 95% confidence The document is a detailed legal work report from Beijing Grandway Law Offices regarding the application for the initial public offering (IPO) and listing of Tibet Yiming Xiya Pharmaceutical Technology Co., Ltd. It includes extensive legal opinions, verification of the company's qualifications, compliance with laws and regulations, and detailed descriptions of the IPO process, shareholder meetings, board authorizations, and financial audits. The document references the audit report, internal control report, and other legal and regulatory compliance documents related to the IPO. The length is substantial (15,000 characters), and the content is the actual legal work report, not merely an announcement or certification. This type of document is a specialized legal opinion report related to the IPO process, which fits best under the category of Audit Report / Information (AR), as it includes audit results, legal compliance verification, and internal control assessments but is not the full annual report or financial statements themselves. Therefore, the classification is AR with high confidence. FY 2015
2016-11-13 Chinese
华西证券股份有限公司关于公司首次公开发行股票并上市之发行保荐工作报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report from 华西证券股份有限公司 regarding the IPO sponsorship work for 西藏易明西雅医药科技股份有限公司. It includes extensive descriptions of the due diligence process, project approval, internal reviews, risk disclosures, and cooperation details related to the IPO. The content focuses on the underwriting and sponsorship activities for the company's initial public offering, including legal, financial, and operational investigations. This type of document is characteristic of a 'Capital/Financing Update' as it relates to the company's fundraising and issuance of new shares for listing. It is not an annual report, audit report, or earnings release, nor is it a simple announcement or presentation. The length and depth confirm it is a substantive report on the IPO process and sponsorship work.
2016-11-13 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.